Research programme: virus-like particle vaccines - ARTES Biotechnology/Burnet InstituteAlternative Names: HepSeeVaxDelta3™METAVAX® vaccine
Latest Information Update: 02 Aug 2016
At a glance
- Originator ARTES Biotechnology; Burnet Institute
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Hepatitis C
Most Recent Events
- 29 Jul 2016 Early research in Hepatitis C (Prevention) in Australia, Germany